Literature DB >> 11948533

Evaluation of approach to predict the contribution of multiple cytochrome P450s in drug metabolism using relative activity factor: effects of the differences in expression levels of NADPH-cytochrome P450 reductase and cytochrome b(5) in the expression system and the differences in the marker activities.

Miki Nakajima1, Kazuhiro Tane, Sumika Nakamura, Noriaki Shimada, Hiroshi Yamazaki, Tsuyoshi Yokoi.   

Abstract

The concept of relative activity factor (RAF) to extrapolate data obtained with recombinant cytochrome P450(CYP)s to human liver microsomes has been proposed. To evaluate the approach to predict the contribution of multiple CYPs using RAF, we investigated the effects of the differences in the expression levels of NADPH-cytochrome P450 reductase (OR) and cytochrome b(5) (b(5)) in recombinant CYPs from baculovirus-infected insect cells and the differences in the marker activities. Because we previously clarified that azelastine, an antiallergy and antiasthmatic drug, is N-demethylated by CYP1A2, CYP2D6, and CYP3A4 in humans, the reaction was used as a model. For calculation of RAF, three lots of recombinant CYP1A2, CYP2D6, and CYP3A4 from baculovirus-infected insect cells with different expression levels of OR and b(5) were used. The OR/CYP ratios for recombinant CYP1A2, CYP2D6, and CYP3A4 were 3.9-4.8, 5.1-8.7, and 8.0-11.3, respectively. The b(5)/CYP ratio for recombinant CYP3A4 was 2.1-18.7. As marker activities, ethoxyresorufin O-deethylation and phenacetin O-deethylation for CYP1A2, bufuralol 1'-hydroxylation and debrisoquin 4-hydroxylation for CYP2D6, testosterone 6beta-hydroxylation and midazolam 1'-hydroxylation for CYP3A4 were compared. Our results indicated that the differences in the expression levels of OR and b(5) coexpressed in baculovirus-infected insect cells would not be a critical factor for the quantitative prediction using RAF. In addition, we confirmed that differences in the marker activities did not significantly affect the calculation of RAF values, when the marker activities are specific for a certain CYP isoform. It was suggested that the RAF approach using recombinant CYPs from baculovirus-infected insect cells coexpressing OR (and b(5) if required) could be valuable for the prediction of the contribution of each CYP in drug metabolism. Copyright 2002 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 91:952-963, 2002

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11948533     DOI: 10.1002/jps.10091

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Application of CYP3A4 in vitro data to predict clinical drug-drug interactions; predictions of compounds as objects of interaction.

Authors:  Kuresh A Youdim; Aref Zayed; Maurice Dickins; Alex Phipps; Michelle Griffiths; Amanda Darekar; Ruth Hyland; Odette Fahmi; Susan Hurst; David R Plowchalk; Jack Cook; Feng Guo; R Scott Obach
Journal:  Br J Clin Pharmacol       Date:  2008-02-14       Impact factor: 4.335

2.  Human recombinant cytochrome P450 enzymes display distinct hydrogen peroxide generating activities during substrate independent NADPH oxidase reactions.

Authors:  Vladimir Mishin; Diane E Heck; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Sci       Date:  2014-07-24       Impact factor: 4.849

3.  Differences in Methadone Metabolism by CYP2B6 Variants.

Authors:  Sarah Gadel; Christina Friedel; Evan D Kharasch
Journal:  Drug Metab Dispos       Date:  2015-04-20       Impact factor: 3.922

4.  CYP2C9 protein interactions with cytochrome b(5): effects on the coupling of catalysis.

Authors:  Charles W Locuson; Larry C Wienkers; Jeffrey P Jones; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2007-04-19       Impact factor: 3.922

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.